NeuroMicrobiota, European Associated Laboratory, INSERM/UCL, Institut National de la Santé et de la Recherche Médicale, U1048, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), CHU Rangueil, Université Paul Sabatier Toulouse, France.
Front Neurosci. 2015 Feb 24;9:56. doi: 10.3389/fnins.2015.00056. eCollection 2015.
Hypothalamus is a key area involved in the control of metabolism and food intake via the integrations of numerous signals (hormones, neurotransmitters, metabolites) from various origins. These factors modify hypothalamic neurons activity and generate adequate molecular and behavioral responses to control energy balance. In this complex integrative system, a new concept has been developed in recent years, that includes reactive oxygen species (ROS) as a critical player in energy balance. ROS are known to act in many signaling pathways in different peripheral organs, but also in hypothalamus where they regulate food intake and metabolism by acting on different types of neurons, including proopiomelanocortin (POMC) and agouti-related protein (AgRP)/neuropeptide Y (NPY) neurons. Hypothalamic ROS release is under the influence of different factors such as pancreatic and gut hormones, adipokines (leptin, apelin,…), neurotransmitters and nutrients (glucose, lipids,…). The sources of ROS production are multiple including NADPH oxidase, but also the mitochondria which is considered as the main ROS producer in the brain. ROS are considered as signaling molecules, but conversely impairment of this neuronal signaling ROS pathway contributes to alterations of autonomic nervous system and neuroendocrine function, leading to metabolic diseases such as obesity and type 2 diabetes. In this review we focus our attention on factors that are able to modulate hypothalamic ROS release in order to control food intake and energy metabolism, and whose deregulations could participate to the development of pathological conditions. This novel insight reveals an original mechanism in the hypothalamus that controls energy balance and identify hypothalamic ROS signaling as a potential therapeutic strategy to treat metabolic disorders.
下丘脑是参与代谢和食物摄入控制的关键区域,通过整合来自各种来源的众多信号(激素、神经递质、代谢物)。这些因素改变下丘脑神经元的活性,并产生适当的分子和行为反应来控制能量平衡。在这个复杂的整合系统中,近年来出现了一个新概念,即将活性氧物种(ROS)作为能量平衡的关键参与者。ROS 已知在许多不同的外周器官的信号通路中起作用,但也在调节食物摄入和代谢的下丘脑起作用,通过作用于不同类型的神经元,包括促黑皮质素原(POMC)和刺鼠相关蛋白(AgRP)/神经肽 Y(NPY)神经元。下丘脑 ROS 的释放受多种因素的影响,如胰腺和肠道激素、脂肪因子(瘦素、阿立新等)、神经递质和营养素(葡萄糖、脂质等)。ROS 的产生来源包括 NADPH 氧化酶,也包括被认为是大脑中主要 ROS 产生源的线粒体。ROS 被认为是信号分子,但相反,这种神经元信号 ROS 途径的损伤导致自主神经系统和神经内分泌功能的改变,导致代谢疾病,如肥胖和 2 型糖尿病。在这篇综述中,我们关注的是能够调节下丘脑 ROS 释放以控制食物摄入和能量代谢的因素,以及其失调可能参与病理状况的发展。这一新的见解揭示了下丘脑控制能量平衡的一个原始机制,并确定了下丘脑 ROS 信号作为治疗代谢紊乱的潜在治疗策略。